Welcome to our dedicated page for Cbdmd news (Ticker: YCBD), a resource for investors and traders seeking the latest updates and insights on Cbdmd stock.
cbdMD, Inc. (NYSE American: YCBD) generates a steady flow of corporate, financial, and strategic news tied to its position in the hemp-derived wellness and cannabinoid products space. Company press releases and SEC filings highlight developments across its cbdMD and Paw CBD brands, ATRx Labs functional mushroom products, and Herbal Oasis hemp-derived THC social seltzers, as well as capital markets activity and exchange-listing matters.
News for YCBD often covers operating performance, including updates on net sales, gross profit, and operating loss trends disclosed in conjunction with annual and quarterly results. The company has reported multiple years of operating improvement and has discussed cost management, product portfolio optimization, and marketing investments in its communications. Investors following YCBD news also see disclosures about preferred stock financings, such as Series B and Series C Convertible Preferred Stock, and the establishment of an equity line of credit registered on Form S-1.
Regulatory and listing-related announcements form another key part of cbdMD’s news flow. The company has reported regaining full compliance with NYSE American continued listing standards after addressing equity-related deficiencies, and it has furnished related information through Form 8-K filings. Policy commentary around federal discussions on cannabinoids and hemp-derived products, and how those discussions may affect research and investment in the category, also appears in its releases.
Strategic updates, including the asset acquisition of Gaia Botanicals, LLC and its Bluebird Botanicals brand and online CBD marketplace, are disclosed through press releases and 8-K filings. These items provide detail on how cbdMD is expanding its brand portfolio, intellectual property base, and product offerings in CBD and related categories. For investors and observers, the YCBD news page offers a centralized view of earnings communications, capital transactions, regulatory milestones, and brand-level initiatives across cbdMD’s wellness platform.
cbdMD, Inc. announced a conference call on December 16, 2021, at 4:15 p.m. Eastern Time to discuss its financial results for the fourth quarter and fiscal year ending September 30, 2021. This session will cover key business developments, and there are options for both domestic and international callers to join. The company is recognized for its extensive line of THC-free CBD products and is committed to transparency in its financial performance and future outlook.
cbdMD, Inc. (NYSE American: YCBD, YCBDpA) has appointed Dave Johnson as Senior Vice President of Business Development. With over 30 years in the consumer goods sector, including 20 years at PepsiCo (NASDAQ: PEP), Johnson will spearhead cbdMD's initiatives in expanding retail distribution across the U.S. He believes the CBD industry will experience significant growth in the next two years, positioning cbdMD to capitalize on this trend through its brands, including cbdMD and Paw CBD, and the new cbdMD Botanicals line.
cbdMD, Inc. (YCBD, YCBDPA) announced a multi-year exclusive agreement with Amify, an Amazon.com, Inc. (AMZN) partner, to launch CBD products on Amazon once the category is approved. This partnership includes cbdMD's leading products, such as gummies, tinctures, and skin care from cbdMD Botanicals. The agreement follows the growing interest in CBD since the Farm Bill's passage in 2018, positioning cbdMD to optimize its strategy for Amazon's platform. The company's Chairman emphasized readiness for market entry, enhancing cbdMD's distribution channels.
cbdMD, Inc. (NYSE: YCBD) has extended its advertising partnership with Spotify (NYSE: SPOT) and the Joe Rogan Experience (JRE) through 2022. The collaboration, which began in 2019, allows the company to tap into JRE's extensive audience, enhancing brand visibility in the CBD market. Co-CEO Martin Sumichrast emphasized the significance of this partnership, highlighting Rogan's credibility as a customer and advocate for the CBD community. cbdMD offers over 130 THC-free CBD products, contributing to its status as a leading brand in the industry.
cbdMD, Inc. (NYSE American: YCBD) will participate in the Jefferies Virtual West Coast Consumer Conference on November 16, 2021, with a fireside chat scheduled to begin at 9:50 AM ET. Investors can listen live via this link. cbdMD is a leading CBD brand, offering over 130 THC-free products including tinctures, gummies, and topicals, as well as a range of pet and beauty products. The company focuses on providing high-grade, U.S.-produced CBD solutions to consumers.
cbdMD, Inc. (NYSE American: YCBD) has appointed Matt Coapman as Chief Marketing Officer, bringing over 15 years of digital marketing and eCommerce experience. Previously, he was a Partner at Dingoz Consulting and the VP of Marketing for blu eCigs, where he significantly enhanced brand recognition. Coapman aims to drive sustainable growth, improve customer engagement, and enhance brand messaging within the CBD industry. cbdMD offers over 130 THC-free CBD products, including various SKUs for humans and pets, positioning itself as a leader in the market.
cbdMD, Inc. (NYSE American: YCBD) celebrated success at the Rogue Invitational, with athletes Justin Medeiros and Annie Thorisdottir winning gold and silver medals, respectively. The event took place in Austin, Texas, featuring top competitors in CrossFit. Medeiros praised his recovery routine post-CrossFit Games as key to his victory, while Thorisdottir expressed pride in her team's accomplishments. cbdMD's EVP of Sports Marketing, Hans Molenkamp, highlighted the athletes' achievements as inspiration, noting the brand's deep ties to the CrossFit community.
cbdMD has announced an exclusive partnership with Wodapalooza, the premier fitness festival happening from January 13-16, 2022, in Miami, Florida. As the Official CBD Partner, cbdMD will provide wellness solutions, product samples, and educational materials to athletes and gym owners. This partnership follows cbdMD's successful activation at the 2021 NOBULL CrossFit Games and aims to enhance its brand presence in the functional fitness community. The event will feature over $500k in prize money and aims to elevate the fitness community experience.
cbdMD, Inc. (NYSE American: YCBD) announced on October 7 the launch of cbdMD Therapeutics, a research division partnering with the University of Mississippi's National Center for Natural Products Research. The collaboration focuses on identifying and patenting novel cannabinoids for therapeutic use. Research will explore minor cannabinoids' chemistry, biology, and receptor activity, commencing in Fall 2021. Dr. Sibyl Swift emphasizes that this work sets a new standard in the cannabinoid industry, aiming for significant consumer benefits.
cbdMD, Inc. has entered a three-year exclusive partnership with Troon, the largest golf management company, to promote cbdMD products across over 600 affiliated facilities worldwide. This collaboration aims to enhance distribution opportunities for cbdMD's renowned CBD products, leveraging Troon's extensive network in the golf sector. The partnership features marketing initiatives including displays for retail locations, aiming to engage millions of golfing enthusiasts. This strategic move aligns with cbdMD's goal to expand its market reach, leveraging its brand ambassadors, including professional golfers.